Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Cash from Investing Activities (2022 - 2025)

Corvus Pharmaceuticals has reported Cash from Investing Activities over the past 4 years, most recently at $10.9 million for Q4 2025.

  • Quarterly results put Cash from Investing Activities at $10.9 million for Q4 2025, up 278.86% from a year ago — trailing twelve months through Dec 2025 was -$7.8 million (up 71.63% YoY), and the annual figure for FY2025 was -$7.8 million, up 71.63%.
  • Cash from Investing Activities for Q4 2025 was $10.9 million at Corvus Pharmaceuticals, up from -$2.6 million in the prior quarter.
  • Over the last five years, Cash from Investing Activities for CRVS hit a ceiling of $17.5 million in Q3 2023 and a floor of -$25.6 million in Q1 2022.
  • Median Cash from Investing Activities over the past 4 years was -$2.5 million (2023), compared with a mean of -$2.7 million.
  • Biggest five-year swings in Cash from Investing Activities: tumbled 308.11% in 2024 and later skyrocketed 60714.29% in 2025.
  • Corvus Pharmaceuticals' Cash from Investing Activities stood at -$3.9 million in 2022, then skyrocketed by 40.29% to -$2.3 million in 2023, then crashed by 162.42% to -$6.1 million in 2024, then surged by 278.86% to $10.9 million in 2025.
  • The last three reported values for Cash from Investing Activities were $10.9 million (Q4 2025), -$2.6 million (Q3 2025), and -$20.3 million (Q2 2025) per Business Quant data.